undamentalytics Newsletter

Havencrest Healthcare Partners, L.P.: insider trades

10% owner at Starling Oncology, Inc. No open-market purchases and 13 sales not made under a pre-set plan, reported from August 23, 2022 to January 30, 2024.

What happened after Havencrest Healthcare Partners, L.P.’s sales?

After their sales, the shares moved −91.8% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Havencrest Healthcare Partners, L.P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 3 −76.5% −78.8% 100% 1 — — Not enough years
Sales, 12 months after the report 3 −91.8% −95.5% 100% 1 — — Not enough years
Sales, 12 months after the trade 2 −95.2% −95.2% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Starling Oncology, Inc. STLN —013August 23, 2022January 30, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
January 30, 2024January 29, 2024 STLN Sale $18,310 not yetnot yetnot yet
January 26, 2024January 24, 2024 STLN Sale $96,835 not yetnot yetnot yet
November 15, 2022November 11, 2022 STLN Sale $851,198 not yetnot yetnot yet
November 10, 2022November 8, 2022 STLN Sale $517,297 not yetnot yetnot yet
November 7, 2022November 3, 2022 STLN Sale $395,936 not yetnot yetnot yet
November 2, 2022October 31, 2022 STLN Sale $640,949 not yetnot yetnot yet
October 28, 2022October 26, 2022 STLN Sale $701,170 not yetnot yetnot yet
October 20, 2022October 18, 2022 STLN Sale $196,346 −78.8%−84.2%not yet
October 4, 2022September 30, 2022 STLN Sale $244,329 not yetnot yetnot yet
September 29, 2022September 27, 2022 STLN Sale $222,697 not yetnot yetnot yet
September 26, 2022September 22, 2022 STLN Sale $110,826 not yetnot yetnot yet
August 31, 2022August 29, 2022 STLN Sale $489,415 −80.3%−95.8%−97.2%
August 23, 2022August 19, 2022 STLN Sale $620,434 −70.3%−95.5%−93.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Havencrest Healthcare Partners, L.P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.